TuHURA Biosciences
HURA
2 hedge funds and large institutions have $498K invested in TuHURA Biosciences in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
33% less funds holding
Funds holding: 3 → 2 (-1)
53% less capital invested
Capital invested by funds: $1.07M → $498K (-$572K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$107K |
| 2 |
DOA
D'Orazio & Associates
Falls Church,
Virginia
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJFSA
1
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $413K | – | – | – |
|
2
Goldman Sachs
New York
| $48K | – | – | – |
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $34K | – | – | – |
|
|
HFM
4
Hartford Financial Management
Hartford,
Connecticut
| $1K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
6
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
SIM
7
Spark Investment Management
New York
| – | -$107K | -1 | Closed |
|
|
DOA
8
D'Orazio & Associates
Falls Church,
Virginia
| – | -$3K | – | – |
|
HURA Hedge Fund Activity: Q4 2016 in Review
2 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2016, worth a combined $498K — down 53% from $1.07M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HURA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Spark Investment Management, exiting entirely with an estimated $107K sold.
- 2 institutional investors held TuHURA Biosciences (HURA) as of Q4 2016, down from 3 in Q3 2016.
- Funds reported $498K of TuHURA Biosciences stock for Q4 2016, down 53% quarter-over-quarter.
- 0 funds opened new TuHURA Biosciences positions in Q4 2016 and 1 closed out, a net change of -1 holder.
- The largest TuHURA Biosciences seller in Q4 2016 was Spark Investment Management, an estimated $107K sold.
Based on aggregated 13F filings for Q4 2016.